<DOC>
	<DOCNO>NCT01224470</DOCNO>
	<brief_summary>Dexmedetomidine new selective potent alpha-2 agonist . It centrally act anesthetic property . It known intrathecal addition alpha-2 adrenergic agent result prolongation duration sensory motor blockade induce hyperbaric bupivacaine . But effect intravenous dexmedetomidine spinal block evaluate . The aim study assess effect intravenous dexmedetomidine low-dose spinal anesthesia transurethral surgery .</brief_summary>
	<brief_title>The Effects Intravenous Dexmedetomidine Spinal Anesthesia Using Low Dose Diluted Bupivacaine Transurethral Resection Prostate</brief_title>
	<detailed_description />
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>ASA class I II Elective transurethral prostatectomy age &gt; 20 Coagulation deficiency infection back Congestive heart failure arrythmia Chronic alcoholic disease Antidepressants therapy</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>